RNAi innovation is shaping a new phase in beauty science. L’Oréal recently expanded its partnership with South Korean biotech company OliX. The collaboration now includes nail health research alongside existing skin and hair studies. Moreover, both companies aim to develop advanced cosmetic solutions using RNA interference technology.
L’Oréal first partnered with OliX in 2025 for hair and skin applications. However, the latest agreement broadens the research scope significantly. OliX will lead candidate discovery and scientific development. Meanwhile, L’Oréal will contribute beauty expertise and formulation knowledge.
Targeted Cosmetic Solutions Gain Momentum With RNAi Innovation
The technology focuses on controlling specific gene activity. Therefore, researchers believe RNAi innovation can support healthier nails and stronger growth. The collaboration could also introduce highly targeted cosmetic treatments in the future.
Additionally, OliX uses its proprietary RNA platform for multiple therapeutic projects. The company continues expanding its presence in beauty-focused biotechnology. Industry experts also expect stronger demand for science-backed cosmetic solutions worldwide.
Scientific Partnerships Continue Transforming RNAi Innovation
The beauty industry increasingly invests in advanced scientific partnerships. Consequently, brands now explore biotechnology to create personalized and effective products. L’Oréal’s expanded collaboration reflects this growing industry direction.
Furthermore, the partnership strengthens L’Oréal’s position in innovation-led beauty research. Both companies plan to accelerate product discovery through combined scientific capabilities. As a result, consumers may eventually see more specialized beauty treatments enter the market.
